The following is a roundup of top developments in the biotech space over the last 24 hours. ... (Biotech stocks that hit 52-week highs on Dec. ... presented interim data at the San Antonio Breast Cancer Symposium from the ongoing ...
News
- The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third ...
- Biothera unveils updated data from Phase 2 mTNBC trial at SABCS
Biothera Pharmaceuticals is a renowned biotechnology company ... -triple-negative-breast-cancer-patients-at-san-antonio-breast-cancer-symposium/.
- Global Medical Equipment Calibration Service Market, Top key players are Biomed Technologies ...
Top key players are @ Biomed Technologies, NS Medical Systems, JPen Medical, Tektronix, Fluke Biomedical, JM Test ... 1604 W San Antonio,.
- SABCS: Foundation's blood test predicts early relapses in triple-negative breast cancer
The ongoing study, presented at the San Antonio Breast Cancer Symposium, enrolled 196 women and sequenced circulating tumor DNA in 142 ...
- Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio ...
13, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), ... a poster at the AACR San Antonio Breast Cancer Symposium in San Antonio, ...